Table 3.
Desired measures to improve the MIB
| Desired improvement | Specific suggestions/examplesa |
|---|---|
| Reordering of information and/or headings | Include directions for use in position of higher prominence |
| Move active ingredient to a less prominent position | |
| Colour | Coloured fonts, background(s) |
| Colour coding of different sections (UK) | |
| Convey warnings using red | |
| Bolding for emphasis | Use bolding to emphasize warnings information |
| Bold ‘not’ in ‘Do not…’ | |
| Bold key precautions/contraindications terms (Australia) | |
| Bold subheadings (Australia) | |
| Picture or pictogram use | ‘Tick cross’ pictogram system |
| Content | Content addition: contact details (Australia), inactive ingredient information, expiry date (UK) |
| Omit active ingredient from MIB | |
| Content reduction (UK): ‘when using this product’ information, some actions required to be taken (statements referring to speak to a health‐care professional or read the enclosed leaflet), ‘Storage’ heading | |
| Rewording of headings | Headings should be direct statements corresponding to action to be taken (Australia) |
| ‘Warnings and allergy information’ to be replaced with: ‘Precautions’ (perceived to be more friendly than ‘Warning’) (UK) | |
| ‘Directions’ to be replaced with: ‘Dosage’ (UK); ‘How to take this medicine’ (Australia) | |
| ‘When using this product’ to be replaced with: ‘Attention’ or ‘Warning’ (UK); ‘Do not take/use if’ (Australia) | |
| Other formatting changes | Split MIB across multiple panels |
| Use of a thin line to subdivide subsections under one heading (Australia) | |
| Distinct, separate sections similar to the Benadryl® Dry, Tickly Cough label (UK) |
a
Suggestions were provided by both Australian and UK cohorts, unless specified otherwise.